Drug design from the cryptic inhibitor envelope
The conformational dynamics of a compound has a large effect on ligand/receptor binding. Here, the authors employ NMR spectroscopy to study ligand binding to the enzyme LpxC, discovering an inhibitor envelope that was not identifiable by crystallography and subsequently developing a highly potent in...
Saved in:
Main Authors: | Chul-Jin Lee, Xiaofei Liang, Qinglin Wu, Javaria Najeeb, Jinshi Zhao, Ramesh Gopalaswamy, Marie Titecat, Florent Sebbane, Nadine Lemaitre, Eric J. Toone, Pei Zhou |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2016
|
Subjects: | |
Online Access: | https://doaj.org/article/d7d0d77eb2224e92ad9e99b31e87c12f |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Curative Treatment of Severe Gram-Negative Bacterial Infections by a New Class of Antibiotics Targeting LpxC
by: Nadine Lemaître, et al.
Published: (2017) -
The Lipid A 1-Phosphatase, LpxE, Functionally Connects Multiple Layers of Bacterial Envelope Biogenesis
by: Jinshi Zhao, et al.
Published: (2019) -
Avoiding Drug Resistance by Substrate Envelope-Guided Design: Toward Potent and Robust HCV NS3/4A Protease Inhibitors
by: Ashley N. Matthew, et al.
Published: (2020) -
Mechanism of inhibition of enveloped virus membrane fusion by the antiviral drug arbidol.
by: Elodie Teissier, et al.
Published: (2011) -
Cryptic contamination and phylogenetic nonsense.
by: Anna Linderholm, et al.
Published: (2008)